Ultragenyx PharmaceuticalRARE
那斯達克 · USD
21.43
-0.78
(-3.51%)
盤中 03/13 02:09 (UTC+8)
03/13 02:09 (UTC+8)
Ultragenyx PharmaceuticalRARE
21.43
-0.78
(-3.51%)
財務數據
損益表
- 0.98
- 1.27
- 1.09
- 1.47
- 1.39
- 1.65
- 1.39
- 1.66
- 1.60
- 2.07
- -9.47
- 29.92
- -14.57
- 35.09
- -5.12
- 18.20
- -15.52
- 19.53
- -3.94
- 29.60
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 207,279 | 159,933 | 166,496 | 139,292 | 164,877 | 139,494 | 147,026 | 108,833 | 127,392 | 98,052 |
營業成本 | 29,345 | 27,991 | 23,002 | 28,662 | 16,894 | 21,021 | 21,280 | 17,533 | 12,051 | 10,987 |
營業毛利 | 177,934 | 131,942 | 143,494 | 110,630 | 147,983 | 118,473 | 125,746 | 91,300 | 115,341 | 87,065 |
營業費用 | 291,217 | 302,832 | 251,382 | 253,569 | 270,261 | 250,460 | 242,107 | - | 237,390 | 232,162 |
研發費用 | 203,280 | 216,212 | 164,736 | 165,772 | 187,766 | 170,109 | 161,503 | 178,487 | 160,557 | 157,245 |
推銷及管理費用 | 87,937 | 86,620 | 86,646 | 87,797 | 82,495 | 80,351 | 80,604 | 78,160 | 76,833 | 74,917 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -113,283 | -170,890 | -107,888 | -142,939 | -122,278 | -131,987 | -116,361 | -165,347 | -122,049 | -145,097 |
其他收入及費用 | 5,578 | 4,820 | 7,934 | 7,668 | 5,944 | 13,808 | 5,572 | 7,219 | 10,596 | 5,182 |
利息費用 | 19,469 | 14,148 | 14,041 | 14,342 | 15,522 | 15,712 | 15,960 | 15,847 | 17,328 | 17,665 |
稅前純益 | -127,686 | -179,540 | -114,004 | -149,770 | -133,404 | -133,213 | -130,740 | -170,229 | -126,892 | -158,999 |
所得稅 | 870 | 873 | 947 | 1,310 | -19 | 303 | 858 | 455 | -3,702 | 650 |
稅後純益 | -128,556 | -180,413 | -114,951 | -151,080 | -133,385 | -133,516 | -131,598 | -170,684 | -123,190 | -159,649 |
基本每股稅後盈餘(元) | -1.29 | -1.81 | -1.17 | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 | -1.52 | -2.23 |
稀釋每股稅後盈餘(元) | -1.28 | -1.81 | -1.17 | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 | -1.44 | -2.23 |
基本平均股數(千股) | 99900.00 | 99771.00 | 98460.00 | 96288.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 | 81118.00 | 71664.00 |
稀釋平均股數(千股) | 99900.00 | 99771.00 | 98460.00 | 96288.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 | 81118.00 | 71664.00 |
還原基本每股稅後盈餘(元) | -1.29 | -1.81 | -1.17 | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 | -1.52 | -2.23 |
還原稀釋每股稅後盈餘(元) | -1.28 | -1.81 | -1.17 | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 | -1.44 | -2.23 |
還原基本平均股數(千股) | 99,900 | 99,771 | 98,460 | 96,288 | 95,681 | 95,493 | 86,580 | 84,286 | 81,118 | 71,664 |
還原稀釋平均股數(千股) | 99,900 | 99,771 | 98,460 | 96,288 | 95,681 | 95,493 | 86,580 | 84,286 | 81,118 | 71,664 |
EBITDA(千元) | -99,948 | -157,490 | -92,391 | -128,171 | -111,609 | -111,859 | -108,865 | -149,293 | -105,294 | -136,824 |